title: [News on melanoma from the 2010 Dermatology Days in Paris].
authors.affiliation: Service de dermatologie, hôpital La Grave, place Lange, TSA 60033, 31059 Toulouse cedex 9, France. boulinguez.s@chu-toulouse.fr
authors.forename: Serge
authors.initials: S
authors.lastname: Boulinguez
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000008:administration & dosage; D014408:Biomarkers, Tumor / Q000378:metabolism; D017024:Chemotherapy, Adjuvant; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003880:Dermatology / Q000639:trends; D019317:Evidence-Based Medicine; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000235:genetics / Q000517:prevention & control / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D009154:Mutation; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D011725:Pyridines / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000517:prevention & control / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D000077157:Sorafenib; D000077204:Temozolomide; D016896:Treatment Outcome
chemical_list: D001557:Benzenesulfonates; D014408:Biomarkers, Tumor; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D003606:Dacarbazine; D000077157:Sorafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D000077204:Temozolomide